Hua Linghu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hua Linghu has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Ruo-Nan Li
Department of Gynecology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
3 shared publicationsBin Liu
The First Affiliated Hospital of Chongqing Medical University
2 shared publicationsXing Wei
Department of Gynecology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
2 shared publications- Binbin Ma
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
1 shared publication Dong-Mei Xu
Chongqing Medical University
1 shared publicationHui Wang
Chongqing Medical University
1 shared publication
Latest Publications
- 28 March 2022
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (6) , 1417-1423
Lymphadenectomy in Primary Fallopian Tube Cancer is Associated with Improved Survival
Primary fallopian tube cancer (PFTC) shares the same diagnostic and management guidelines with epithelial ovarian cancer (EOC). The LION trail raised concerns regarding the role of systematic pelvi...
- 28 March 2022
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (6) , 1417-1423
Lymphadenectomy in Primary Fallopian Tube Cancer is Associated with Improved Survival
Primary fallopian tube cancer (PFTC) shares the same diagnostic and management guidelines with epithelial ovarian cancer (EOC). The LION trail raised concerns regarding the role of systematic pelvi...
- Open Access
- 6 March 2021
- Published by Springer Nature in Research Square
Uterine Carcinoma With Complex Reasons for Hypercalcemia: a Case Report and Review of the Literature
Introduction: Large-cell neuroendocrine carcinoma (LCNEC) is a seldom seen histological subtype of endometrial cancer with aggressive behavior and poor prognosis. Among current literatures, no one was found to be hormonally functional.Case presentation: We reported a rare case of endometrial LCNEC expressing both parathyroid hormone (PTH) and parathyroid hormone-related protein (PTH-rp). With ectopic PTH secreted into the blood stream, the hypercalcemia caused by malignant existence and osseous metastasis were concealed and misled initially. Literature review: Systematic literature search of previously reported uterine large cell neuroendocrine carcinomas and ectopic PTH-secreting neuroendocrine tumor (NET) cases were conducted in PubMed/MEDLINE databases respectively. We identified 55 cases of uterine LCNEC and 7 cases of PTH-secreting NET. Clinicopathologic characteristics, treatment and prognosis of all collected cases were summarized. Conclusion: Although quite rare, endometrial cancer can be functional and secret ectopic hormone, causing confusing clinical features. This case demonstrated the challenge in diagnosing malignancy-associated refractory hypercalcemia.
- 6 March 2021
- Published by Springer Nature in Research Square
Open AccessUterine Carcinoma With Complex Reasons for Hypercalcemia: a Case Report and Review of the Literature
Introduction: Large-cell neuroendocrine carcinoma (LCNEC) is a seldom seen histological subtype of endometrial cancer with aggressive behavior and poor prognosis. Among current literatures, no one was found to be hormonally functional.Case presentation: We reported a rare case of endometrial LCNEC expressing both parathyroid hormone (PTH) and parathyroid hormone-related protein (PTH-rp). With ectopic PTH secreted into the blood stream, the hypercalcemia caused by malignant existence and osseous metastasis were concealed and misled initially. Literature review: Systematic literature search of previously reported uterine large cell neuroendocrine carcinomas and ectopic PTH-secreting neuroendocrine tumor (NET) cases were conducted in PubMed/MEDLINE databases respectively. We identified 55 cases of uterine LCNEC and 7 cases of PTH-secreting NET. Clinicopathologic characteristics, treatment and prognosis of all collected cases were summarized. Conclusion: Although quite rare, endometrial cancer can be functional and secret ectopic hormone, causing confusing clinical features. This case demonstrated the challenge in diagnosing malignancy-associated refractory hypercalcemia.
- Open Access
- 27 April 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (5) , 917
Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway
The abnormal elevation of sulfiredoxin (Srx/SRXN1)—an antioxidant enzyme whose main function is to protect against oxidative stress—has been shown to be closely correlated with the progression of several types of cancer, including human cervical cancer. However, the molecular mechanism by which Srx promotes tumor progression, especially cancer metastasis in cervical cancer, has not been elucidated. Here, we show that Srx expression gradually increases during the progression of human cervical cancer and its expression level is closely correlated with lymph node metastasis. Our study also reveals a significant positive correlation between the expression of Srx and β-catenin in cervical cancer tissues. Loss-of-function studies demonstrate that Srx knockdown using a lentiviral vector-mediated specific shRNA decreases the migration and invasion capacity in HeLa (human papilloma virus 18 type cervical cancer cell line) and SiHa SiHa (cervical squamous cancer cell line). Notably, the exact opposite effects were observed in gain-of-function experiments in C-33A cells. Mechanistically, downregulation or upregulation of Srx leads to an altered expression of proteins associated with the Wnt/β-catenin signaling pathway. Furthermore, blockage of the Wnt/β-catenin signaling pathway contributed to attenuated Srx expression and resulted in significant inhibition of cell migration and invasion in cervical cancer cell lines. Combined, Srx might be an oncoprotein in cervical cancer, playing critical roles in activating the Wnt/β-catenin signaling pathway; it may therefore be a therapeutic target for cervical cancer.
- 27 April 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (5) , 917
Open AccessSulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway
The abnormal elevation of sulfiredoxin (Srx/SRXN1)—an antioxidant enzyme whose main function is to protect against oxidative stress—has been shown to be closely correlated with the progression of several types of cancer, including human cervical cancer. However, the molecular mechanism by which Srx promotes tumor progression, especially cancer metastasis in cervical cancer, has not been elucidated. Here, we show that Srx expression gradually increases during the progression of human cervical cancer and its expression level is closely correlated with lymph node metastasis. Our study also reveals a significant positive correlation between the expression of Srx and β-catenin in cervical cancer tissues. Loss-of-function studies demonstrate that Srx knockdown using a lentiviral vector-mediated specific shRNA decreases the migration and invasion capacity in HeLa (human papilloma virus 18 type cervical cancer cell line) and SiHa SiHa (cervical squamous cancer cell line). Notably, the exact opposite effects were observed in gain-of-function experiments in C-33A cells. Mechanistically, downregulation or upregulation of Srx leads to an altered expression of proteins associated with the Wnt/β-catenin signaling pathway. Furthermore, blockage of the Wnt/β-catenin signaling pathway contributed to attenuated Srx expression and resulted in significant inhibition of cell migration and invasion in cervical cancer cell lines. Combined, Srx might be an oncoprotein in cervical cancer, playing critical roles in activating the Wnt/β-catenin signaling pathway; it may therefore be a therapeutic target for cervical cancer.
- 20 September 2008
- Published by Chinese Journal of Cancer Research in Chinese Journal of Cancer Research
- Vol. 20 (3) , 181-185
Preoperative arterial interventional chemotherapy on cervical cancer
To discuss the therapeutic effect of preoperative interventional chemotherapy on cervical cancer.
- 20 September 2008
- Published by Chinese Journal of Cancer Research in Chinese Journal of Cancer Research
- Vol. 20 (3) , 181-185
Preoperative arterial interventional chemotherapy on cervical cancer
To discuss the therapeutic effect of preoperative interventional chemotherapy on cervical cancer.
- 1 June 2008
- Published by Chinese Journal of Cancer Research in Chinese Journal of Cancer Research
- Vol. 20 (2) , 121-125
Adaptor protein Crk is implicated in mucus formation in mucinous epithelial ovarian cancer (mEOC) cells MCAS
The mucus production is an indicator for the histological grade of mucinous epithelial ovarian cancer (mEOC). In our previous study, Crk expression was targeted in the human ovarian mucinous adenocarcinoma cell line MCAS through RNA interference, resulting in the establishment of Crk knock down cells. These cells exhibited decreased tumorigenic potential both in vitro and in vivo. The purpose of this study was to investigate if there is any change in the capability of forming mucus in these Crk knock down cells.
- 1 June 2008
- Published by Chinese Journal of Cancer Research in Chinese Journal of Cancer Research
- Vol. 20 (2) , 121-125
Adaptor protein Crk is implicated in mucus formation in mucinous epithelial ovarian cancer (mEOC) cells MCAS
The mucus production is an indicator for the histological grade of mucinous epithelial ovarian cancer (mEOC). In our previous study, Crk expression was targeted in the human ovarian mucinous adenocarcinoma cell line MCAS through RNA interference, resulting in the establishment of Crk knock down cells. These cells exhibited decreased tumorigenic potential both in vitro and in vivo. The purpose of this study was to investigate if there is any change in the capability of forming mucus in these Crk knock down cells.